Riskpilot← Back to searchSign inGet full accessAHernández Läkarkonsult AB
ABActiveOrg 5590394556Byggmästaregatan 5 A Lgh 1202General medical practice activities · NACE 8621Est. 20151 employees
Revenue 2025
SEK 409K
+77% vs 2024
EBITDA margin
22.0%
+197% vs 2024
Equity ratio
37.5%
Financial strength
Net profit 2025
SEK 90K
+196% vs 2024
| Revenue | SEK 409K | +77% |
| EBITDA | SEK 90K | +197% |
| Net profit | SEK 90K | +196% |
| Total assets | SEK 278K | +133% |
| Equity | SEK 104K | +120% |
| Employees | 1 | — |
Legal name
AHernández Läkarkonsult AB
Org number
5590394556
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 december 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolagets verksamhet ska vara att bedriva läkarkonsultverksamhet inom primär- och slutenvård, handleda, föreläsa och anordna workshops inom psykologi samt idka därmed förenlig verksamhet.
Address
Byggmästaregatan 5 A Lgh 1202
Email
andres.antillon@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 611 | 202 | 429 | 231 | 409 |
| Staff expenses | — | −67 | −68 | −75 | −127 |
| EBITDA | −144 | −111 | 182 | −92 | 90 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −144 | −111 | 182 | −92 | 90 |
| Net financials | −1 | −1 | −2 | −0 | −0 |
| Profit before tax | −145 | −112 | 180 | −93 | 90 |
| Tax | −0 | — | — | — | — |
| Net profit | −145 | −112 | 180 | −93 | 90 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 263 | 100 | 326 | 119 | 278 |
| Equity | −27 | −139 | 41 | 47 | 104 |
| Long-term debt | 71 | 154 | 154 | 0 | — |
| Short-term debt | 219 | 84 | 130 | 72 | 174 |
| Total debt | 290 | 238 | 284 | 72 | 174 |
EBITDA margin
22.0%
This company
15.8%
Market median
+39% vs market
20212025
Equity ratio
37.5%
This company
38.2%
Market median
+2% vs market
20212025
Return on equity
86.2%
This company
18.4%
Market median
+368% vs market
20212025
Net profit margin
21.9%
This company
8.1%
Market median
+170% vs market
20212025
Asset turnover
1.47×
This company
1.12×
Market median
+31% vs market
20212025
Debt / equity
1.67×
This company
0.62×
Market median
-169% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AHernández Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Carola Susanne Hallqvist | Deputy Board Member | 0 companies |
| Guillermo Andres Antillon Hernandez | Board of Directors | 0 companies |
| Elin Maria Waxin | Deputy Board Member | 0 companies |